Zobrazeno 1 - 2
of 2
pro vyhledávání: '"ABBY MEYERS"'
Autor:
KATRINA B. DIETSCHE, ANNA ZENNO, ALFREDO VILLALOBOS-PEREZ, SYDNEY A. DIXON, MICHAEL S. STAGLIANO, LILIAN MABUNDO, EILEEN L. SHOUPPE, DORIS E. ESTRADA, ABBY MEYERS, FRAN R. COGEN, MARY WALTER, PETER WALTER, STEPHANIE T. CHUNG
Publikováno v:
Diabetes. 71
Metformin is the first-line therapy for youth-onset type 2 diabetes mellitus (Y-T2D) but is suboptimal in up to 50% of youth. The reasons for increased failure rates are unknown. Metformin plasma concentration reflects total body distribution and kin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79b9398a20b3bd3b8bb3ec423dbde8f2
https://doi.org/10.2337/db22-991-p
https://doi.org/10.2337/db22-991-p
Autor:
SYDNEY A. DIXON, ABBY MEYERS, KUNANI TUTTLE, LILIAN MABUNDO, MICHAEL S. STAGLIANO, ALFREDO VILLALOBOS-PEREZ, KATRINA B. DIETSCHE, AMBER B. COURVILLE, DORIS E. ESTRADA, STEPHANIE T. CHUNG
Publikováno v:
Diabetes. 71
Metformin is the only first-line oral agent for youth with type 2 diabetes mellitus (Y-T2D) , but efficacy and adherence is complicated by gastrointestinal (GI) side effects. Prebiotic microbiome modulators (MM) may reduce side effects by shifting th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80ec31369c5a1c2f312b8a2992c75e68
https://doi.org/10.2337/db22-990-p
https://doi.org/10.2337/db22-990-p